Myovant Sciences Ltd. Assets, Fair Value Disclosure
Myovant Sciences Ltd. had Assets, Fair Value Disclosure of $70.00 million as of 2020-12-31, per its 10-Q filed 2021-02-11.
Discontinued › Notes › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2021-02-11
- 2020-12-31: Assets, Fair Value Disclosure $70.00M.
- 2020-09-30: Assets, Fair Value Disclosure $69.96M.
- 2020-06-30: Assets, Fair Value Disclosure $69.99M.
- 2020-03-31: Assets, Fair Value Disclosure $18.39M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2020-12-31 | $70.00M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $69.96M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $69.99M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $18.39M 10-Q · filed 2021-02-11 |
| 2019-12-31 | $84.17M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $143.61M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $121.83M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $126.13M 10-K · filed 2020-05-18 |
| 2018-12-31 | $65.33M 10-Q · filed 2019-02-07 |